Developing a universal vaccine to protect against multiple strains of influenza.
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH
This study is looking for ways to make better flu vaccines that can protect you for a longer time against different types of the flu virus, and if you join, you might help test how well these new vaccines work and how safe they are.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10829327 on NIH RePORTER |
What this research studies
This research focuses on creating innovative influenza vaccine candidates that can provide long-lasting protection against various strains of the influenza virus. The approach includes detailed immunologic analyses to guide vaccine design and identify key indicators of protection. Researchers will conduct both laboratory and clinical testing to evaluate the effectiveness and safety of these vaccines. Patients may have the opportunity to participate in clinical trials that assess the new vaccine's ability to generate a strong immune response.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have previously had adverse reactions to flu vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal influenza vaccine that offers broad protection against multiple flu strains, potentially reducing the incidence of influenza and its complications.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, but this approach aims to innovate further and improve upon existing methods.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.